Brain, Vol. 125, No. 4, 765-772,
March 2002
© 2002 Guarantors of Brain
Hypertension and cerebral white matter lesions in a prospective cohort study
1 Department of Epidemiology and Biostatistics, Erasmus University Medical Centre, Rotterdam, 2 Department of Neurology, University Medical Centre Utrecht and 3 Department of Radiology, University Hospital Groningen, The Netherlands
Correspondence to M. M. B. Breteler, Department of Epidemiology and Biostatistics, Erasmus University Medical Centre, PO Box 1738, 3000 DR Rotterdam, The Netherlands E-mail: breteler{at}epib.fgg.eur.nl
White matter lesions are frequently found on cerebral MRI scans of elderly people and are thought to be important in the pathogenesis of dementia. Hyper tension has been associated with the presence of white matter lesions but this has been investigated almost exclusively in cross-sectional studies. We studied prospectively the association of these lesions with the duration and treatment of hypertension. We randomly sampled 1077 subjects aged between 60 and 90 years from two prospective population-based studies. One-half of the study subjects had their blood pressure measured between 1975 and 1978 and the other half between 1990 and 1993. All subjects underwent 1.5 T MRI scanning; white matter lesions in the subcortical and periventricular regions were rated separately. Subjects with hypertension had increased rates of both types of white matter lesion. Duration of hypertension was associated with both periventricular and subcortical white matter lesions. This relationship was influenced strongly by age. For participants with >20 years of hypertension and aged between 60 and 70 years at the time of follow-up, the relative risks for subcortical and periventricular white matter lesions were 24.3 [95% confidence interval (CI) 5.1114.8] and 15.8 (95% CI 3.473.5), respectively, compared with normotensive subjects. Subjects with successfully treated hypertension had only moderately increased rates of subcortical white matter lesions and periventricular white matter lesions (relative risk 3.3, 95% CI 1.38.4 and 2.6, 95% CI 1.06.8, respectively) compared with normotensive subjects. For poorly controlled hypertensives, these relative risks were 8.4 (95% CI 3.122.6) and 5.8 (95% CI 2.116.0), respectively. In conclusion, we found a relationship between long-standing hypertension and the presence of white matter lesions. Our findings are consistent with the view that effective treatment may reduce the rates of both types of white matter lesion. Adequate treatment of hypertension may therefore prevent white matter lesions and the associated cognitive decline.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Soumare, B. Tavernier, A. Alperovitch, C. Tzourio, and A. Elbaz A Cross-Sectional and Longitudinal Study of the Relationship Between Walking Speed and Cognitive Function in Community-Dwelling Elderly People J Gerontol A Biol Sci Med Sci, October 1, 2009; 64A(10): 1058 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Rosenberg Inflammation and White Matter Damage in Vascular Cognitive Impairment Stroke, March 1, 2009; 40(3_suppl_1): S20 - S23. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rosano, H. Aizenstein, J. Brach, A. Longenberger, S. Studenski, and A. B. Newman Special Article: Gait Measures Indicate Underlying Focal Gray Matter Atrophy in the Brain of Older Adults J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2008; 63(12): 1380 - 1388. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Mitchell Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage J Appl Physiol, November 1, 2008; 105(5): 1652 - 1660. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Insel, S. L. Reminger, and C.-P. Hsiao White Matter Hyperintensities and Medication Adherence Biol Res Nurs, October 1, 2008; 10(2): 121 - 127. [Abstract] [PDF] |
||||
![]() |
C. Qiu, M. F. Cotch, S. Sigurdsson, M. Garcia, R. Klein, F. Jonasson, B. E.K. Klein, G. Eiriksdottir, T. B. Harris, M. A. van Buchem, et al. Retinal and Cerebral Microvascular Signs and Diabetes: The Age, Gene/Environment Susceptibility-Reykjavik Study Diabetes, June 1, 2008; 57(6): 1645 - 1650. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Galluzzi, C. Geroldi, L. Benussi, R. Ghidoni, C. Testa, G. Borsci, M. Bonetti, D. Manfellotto, G. Romanelli, R. Zulli, et al. Association of Blood Pressure and Genetic Background With White Matter Lesions in Patients With Mild Cognitive Impairment J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2008; 63(5): 510 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Geerlings, T. den Heijer, P. J. Koudstaal, A. Hofman, and M.M.B. Breteler History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease Neurology, April 8, 2008; 70(15): 1258 - 1264. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L.C. Vogels, W. M. van der Flier, B. van Harten, A. A. Gouw, P. Scheltens, J. M. Schroeder-Tanka, and H. C. Weinstein Brain magnetic resonance imaging abnormalities in patients with heart failure Eur J Heart Fail, October 1, 2007; 9(10): 1003 - 1009. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Staessen, T. Richart, and W. H. Birkenhager Less Atherosclerosis and Lower Blood Pressure for a Meaningful Life Perspective With More Brain Hypertension, March 1, 2007; 49(3): 389 - 400. [Full Text] [PDF] |
||||
![]() |
P. Behl, C. Bocti, R. H. Swartz, F. Gao, D. J. Sahlas, K. L. Lanctot, D. L. Streiner, and S. E. Black Strategic Subcortical Hyperintensities in Cholinergic Pathways and Executive Function Decline in Treated Alzheimer Patients Arch Neurol, February 1, 2007; 64(2): 266 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. van Harten, F.-E. de Leeuw, H. C. Weinstein, P. Scheltens, and G. J. Biessels Brain Imaging in Patients With Diabetes: A systematic review. Diabetes Care, November 1, 2006; 29(11): 2539 - 2548. [Full Text] [PDF] |
||||
![]() |
F.-E. de Leeuw, E. Korf, F. Barkhof, and P. Scheltens White Matter Lesions Are Associated With Progression of Medial Temporal Lobe Atrophy in Alzheimer Disease Stroke, September 1, 2006; 37(9): 2248 - 2252. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Munoz Leukoaraiosis and Ischemia: Beyond the Myth Stroke, June 1, 2006; 37(6): 1348 - 1349. [Full Text] [PDF] |
||||
![]() |
R. Peila, L. R. White, K. Masaki, H. Petrovitch, and L. J. Launer Reducing the Risk of Dementia: Efficacy of Long-Term Treatment of Hypertension Stroke, May 1, 2006; 37(5): 1165 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Hill and J. R. Mitchell White matter lesions and cognition: It's time for randomized trials to preserve intelligence Neurology, February 28, 2006; 66(4): 470 - 471. [Full Text] [PDF] |
||||
![]() |
W. M. van der Flier, E. C.W. van Straaten, F. Barkhof, A. Verdelho, S. Madureira, L. Pantoni, D. Inzitari, T. Erkinjuntti, M. Crisby, G. Waldemar, et al. Small Vessel Disease and General Cognitive Function in Nondisabled Elderly: The LADIS Study Stroke, October 1, 2005; 36(10): 2116 - 2120. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dufouil, J. Chalmers, O. Coskun, V. Besancon, M.-G. Bousser, P. Guillon, S. MacMahon, B. Mazoyer, B. Neal, M. Woodward, et al. Effects of Blood Pressure Lowering on Cerebral White Matter Hyperintensities in Patients With Stroke: The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy Circulation, September 13, 2005; 112(11): 1644 - 1650. [Abstract] [Full Text] [PDF] |
||||
![]() |
F-E de Leeuw, F Barkhof, and P Scheltens Progression of cerebral white matter lesions in Alzheimer's disease: a new window for therapy? J. Neurol. Neurosurg. Psychiatry, September 1, 2005; 76(9): 1286 - 1288. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Rowan, C.M. Morris, S. Stephens, C. Ballard, H. Dickinson, H. Rao, B.K. Saxby, A.T. McLaren, R.N. Kalaria, and R.A. Kenny Impact of Hypertension and Apolipoprotein E4 on Poststroke Cognition in Subjects >75 Years of Age Stroke, September 1, 2005; 36(9): 1864 - 1868. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H.G. Henskens, A. A. Kroon, M. P.J. van Boxtel, P. A.M. Hofman, and P. W. de Leeuw Associations of the Angiotensin II Type 1 Receptor A1166C and the Endothelial NO Synthase G894T Gene Polymorphisms With Silent Subcortical White Matter Lesions in Essential Hypertension Stroke, September 1, 2005; 36(9): 1869 - 1873. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. B. Goldstein, G. Bartzokis, D. Guthrie, and D. Shapiro Ambulatory blood pressure and the brain: A 5-year follow-up Neurology, June 14, 2005; 64(11): 1846 - 1852. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Birns, H. Markus, and L. Kalra Blood Pressure Reduction for Vascular Risk: Is There a Price To Be Paid? Stroke, June 1, 2005; 36(6): 1308 - 1313. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. DeCarli, E. Fletcher, V. Ramey, D. Harvey, and W. J. Jagust Anatomical Mapping of White Matter Hyperintensities (WMH): Exploring the Relationships Between Periventricular WMH, Deep WMH, and Total WMH Burden Stroke, January 1, 2005; 36(1): 50 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Wiseman, B. K. Saxby, E. J. Burton, R. Barber, G. A. Ford, and J. T. O'Brien Hippocampal atrophy, whole brain volume, and white matter lesions in older hypertensive subjects Neurology, November 23, 2004; 63(10): 1892 - 1897. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Elias, M. F. Elias, M. A. Robbins, and M. M. Budge Blood Pressure-Related Cognitive Decline: Does Age Make a Difference? Hypertension, November 1, 2004; 44(5): 631 - 636. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. van Dijk, M. M.B. Breteler, R. Schmidt, K. Berger, L.-G. Nilsson, M. Oudkerk, A. Pajak, S. Sans, M. de Ridder, C. Dufouil, et al. The Association Between Blood Pressure, Hypertension, and Cerebral White Matter Lesions: Cardiovascular Determinants of Dementia Study Hypertension, November 1, 2004; 44(5): 625 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Greenberg, M. E. Gurol, J. Rosand, and E. E. Smith Amyloid Angiopathy-Related Vascular Cognitive Impairment Stroke, November 1, 2004; 35(11_suppl_1): 2616 - 2619. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Roman Age-Associated White Matter Lesions and Dementia: Are These Lesions Causal or Casual? Arch Neurol, October 1, 2004; 61(10): 1503 - 1504. [Full Text] [PDF] |
||||
![]() |
F-E de Leeuw, F Barkhof, and P Scheltens Alzheimer's disease--one clinical syndrome, two radiological expressions: a study on blood pressure J. Neurol. Neurosurg. Psychiatry, September 1, 2004; 75(9): 1270 - 1274. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-K. Kuo and L. A. Lipsitz Cerebral White Matter Changes and Geriatric Syndromes: Is There a Link? J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2004; 59(8): M818 - M826. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maruyama, T. Matsui, H. Tanji, M. Nemoto, N. Tomita, M. Ootsuki, H. Arai, and H. Sasaki Cerebrospinal Fluid Tau Protein and Periventricular White Matter Lesions in Patients With Mild Cognitive Impairment: Implications for 2 Major Pathways Arch Neurol, May 1, 2004; 61(5): 716 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-E. de Leeuw, F. Richard, J. C. de Groot, C. M. van Duijn, A. Hofman, J. van Gijn, and M. M.B. Breteler Interaction Between Hypertension, apoE, and Cerebral White Matter Lesions Stroke, May 1, 2004; 35(5): 1057 - 1060. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Amin, J. L. Carroll, J. L. Jeffries, C. Grone, J. A. Bean, B. Chini, R. Bokulic, and S. R. Daniels Twenty-four-hour Ambulatory Blood Pressure in Children with Sleep-disordered Breathing Am. J. Respir. Crit. Care Med., April 15, 2004; 169(8): 950 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
R J L Walters, N C Fox, J M Schott, W R Crum, J M Stevens, M N Rossor, and D J Thomas Transient ischaemic attacks are associated with increased rates of global cerebral atrophy J. Neurol. Neurosurg. Psychiatry, February 1, 2003; 74(2): 213 - 216. [Abstract] [Full Text] [PDF] |
||||













